In 2012, the Scripps Translational Science Institute (STSI) established a Division of Digital Medicine, which has developed into an internationally recognized leader in all aspects of the clinical implementation of wireless technologies in health and healthcare. Our mission is to guide innovation and the transformation of medicine that has been made possible through the availability of digital technologies. We are accomplishing this through the generation of the high quality knowledge needed to inform the medical community and the public to drive change.
Quell® Opioid Reduction and Pain Relief in Patients with Cancer
This clinical study will assess the impact of Quell wearable pain relief technology on opioid use and pain in cancer patients.
Sensor Technology and Analytics to Monitor, Predict, and Protect Ebola Patients
This proof-of-concept study used wearable, wireless health sensors, a wireless vital sign monitoring platform, and advanced analytics technology to monitor and analyze multiple vital signs of patients either suspects or confirmed to be infected with the Ebola virus.
Wired for Health
The Scripps Wired for Health Study aims to evaluate the impact of using a smartphone enabled “Wireless Monitoring System” in conjunction with a disease wellness and prevention program on the healthcare costs and resource utilization of chronically ill individuals with diabetes, hypertension, and cardiac arrhythmia.
Essential Tremor & Parkinson’s Disease
The aim of the Genetic & Digital Diagnosis of Essential Tremor & Parkinson’s Disease (GAGDET-PD) trial is to determine whether essential tremor, a benign tremor disorder, and Parkinson’s Disease, a neurodegenerative disorder, can be differentiated via combined genetic testing and monitoring of tremors with a wristwatch-like accelerometer device.
Genomic Risk Markers for Atrial Fibrillation Following Cardiac Rhythm Monitoring
The Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Monitoring (GIRAFFE) study is designed to determine whether genetic risk scores for AFib can identify individuals at high risk of undiagnosed AFib.
In partnership with organizations such as Walgreens and Withings, STSI is exploring some of the largest patient-generated datasets in the world to better understand how people make use of activity trackers, health-monitoring devices, and smartphone apps to improve their health.
Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data during Sleep and Wake Cycles
This proof-of-concept study uses the MultiSense™ wearable device, developed by Rhythm Diagnostic Systems, to explore its diagnostic capabilities in individuals suspected of having obstructive sleep apnea.
Reduction of Cost through Immediate Access to High Quality Lumify Smart Device Ultrasound
The Philips Lumify smart device ultrasound allows physicians to conduct ultrasound procedures at the bedside, potentially reducing the number of standard radiologic ultrasounds ordered, and thereby reducing associated costs. This study surveys physician satisfaction with the Lumify device, including ease of use.
There remains enormous untapped potential to do more to lead the transformation of health and health care. STSI intends to help lead that transformation by generating high quality knowledge around digital technology, and through the training of the first generation of digital health scholars.Steven Steinhubl, MD